✦ LIBER ✦

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

✍ Scribed by M. Fonseca; G. Tannus; E. Parisi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI16 Cost Effectiveness of Boceprevir P

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PGI24 Cost Effectiveness of the Combinat

✍ M. Fonseca; G. Tannus; E. Parisi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI21 Cost Effectiveness of the Combinat

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI5 THE COST-EFFECTIVENESS OF PEGINTERF

✍ MC Fonseca; GTB Araujo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Peginterferon alfa-2b plus ribavirin for

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

P.260 Peginterferon alpha-2b plus ribavi

✍ R.M. El-Wakil; M.F. Montasser; M.A. Mansour; T.A. Salman; M.H. El-Batanony; E.H. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 256 KB